Chongqing Rinu Trading Co., Ltd.

For more than 30 years, Hengrui Medicine has always adhered to its original intention of serving patients, strived to protect patients′ healthy life and quality of life, and overcame difficulties to promote high-quality development of the pharmaceutical industry. Hengrui Medicine has been on the list of the top 50 global pharmaceutical companies published by the American Pharmaceutical Manager magazine for six consecutive years; Hengrui Medicine has been on the list of the world′s top 25 pipeline-scale pharmaceutical companies published by Citeline, an internationally renowned consulting organization, for three consecutive years., ranking jump in 2024 It rose to 8th place, setting a new high among Chinese pharmaceutical companies; In the "2023 Hurun Global 500" released by Hurun Research Institute, Hengrui Medicine ranked 366th; In the "China Pharmaceutical R&D Product Line" released by the China Pharmaceutical Industry Information Center over the years "Best Industrial Enterprise", Hengrui Pharmaceuticals has topped the list 11 times.